PeptiDream Inc

PeptiDream Inc

Health CarePharmaceuticals & Biotechnology
  • Price (JPY)4,815.00
  • Today's Change75.00 / 1.58%
  • Shares traded516.40k
  • 1 Year change+6.53%
  • Beta0.9933
Data delayed at least 20 minutes, as of Jul 27 2021 05:26 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 4587:TYO price moved over +2.04% to 4,755.00
  • 4587:TYO trading volume exceeds daily average by +15.30%
  • 4587:TYO price rises above 15-day moving average to 4,895.00 at 10:03 BST

Key statistics

As of last trade, PeptiDream Inc (4587:TYO) traded at 4,815.00, 16.44% above the 52 week low of 4,135.00 set on Aug 28, 2020.
52-week range
4,135.00Aug 28 20206,540.00Feb 08 2021
Markit short selling activity
Previous close4,740.00
Average volume306.46k
Shares outstanding130.01m
Free float96.55m
P/E (TTM)116.71
Market cap605.85bn JPY
EPS (TTM)39.93
Data delayed at least 20 minutes, as of Jul 27 2021 05:26 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.